First National Trust’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-1,402
Closed -$205K 243
2014
Q3
$205K Buy
1,402
+177
+14% +$27.3K 0.04% 238
2014
Q2
$205K Sell
1,225
-165
-12% -$29.4K 0.04% 234
2014
Q1
$276K Sell
1,390
-20
-1% -$3.77K 0.05% 217
2013
Q4
$269K Sell
1,410
-160
-10% -$29.8K 0.05% 217
2013
Q3
$266K Buy
1,570
+109
+7% +$16.9K 0.05% 216
2013
Q2
$222K Buy
+1,461
New +$207K 0.05% 218

Other funds holding CLB

First National Trust's CLB Position: Q4 2014 in Review

First National Trust sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 1,402 shares — an estimated $205K sold.

First National Trust first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $276K in Q1 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • First National Trust reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
  • First National Trust sold 1,402 Core Laboratories shares in Q4 2014, an estimated $205K.
  • First National Trust first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
  • First National Trust's Core Laboratories position peaked at $276K in Q1 2014.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on First National Trust's 13F filing for Q4 2014, filed 28 Jan 2015.